NO20085240L - C-fenyl-1-tioglucitolforbindelse - Google Patents

C-fenyl-1-tioglucitolforbindelse

Info

Publication number: NO20085240L
Authority: NO; Norway
Prior art keywords: alkyl group; compound; conh2; pharmaceutically acceptable; hydrogen atom
Prior art date: 2006-06-29

Application number

NO20085240A

Other languages

English (en)

Norwegian (no)

Inventor

Hiroyuki Kakinuma

Yuko Hashimoto

Takahiro Ol

Hitomi Takahashi

Yohei Kobashi

Original Assignee

Taisho Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-29

Filing date

2008-12-15

Publication date

2009-03-30

2008-12-15 Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd

2009-03-30 Publication of NO20085240L publication Critical patent/NO20085240L/no

Links

125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
150000001875 compounds Chemical class 0.000 abstract 3
230000000694 effects Effects 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
108091006277 SLC5A1 Proteins 0.000 abstract 2
102000058090 Sodium-Glucose Transporter 1 Human genes 0.000 abstract 2
238000010521 absorption reaction Methods 0.000 abstract 2
239000008103 glucose Substances 0.000 abstract 2
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000001424 substituent group Chemical group 0.000 abstract 2
125000003161 (C1-C6) alkylene group Chemical group 0.000 abstract 1
108091006269 SLC5A2 Proteins 0.000 abstract 1
102000058081 Sodium-Glucose Transporter 2 Human genes 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000069 prophylactic effect Effects 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1
230000002485 urinary effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/04—Carbocyclic radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Hematology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Endocrinology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Vascular Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biochemistry (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Child & Adolescent Psychology (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)

NO20085240A 2006-06-29 2008-12-15 C-fenyl-1-tioglucitolforbindelse NO20085240L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2006179971		2006-06-29
PCT/JP2007/063031 WO2008001864A1 (fr)	2006-06-29	2007-06-28	Composé de c-phényl-1-thioglucitol

Publications (1)

Publication Number	Publication Date
NO20085240L true NO20085240L (no)	2009-03-30

Family

ID=38845628

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20085240A NO20085240L (no)	2006-06-29	2008-12-15	C-fenyl-1-tioglucitolforbindelse

Country Status (15)

Country	Link
US (1)	US8115017B2 (fr)
EP (1)	EP2036901B1 (fr)
JP (1)	JP5152519B2 (fr)
KR (1)	KR20090023570A (fr)
CN (1)	CN101479254B (fr)
AU (1)	AU2007266078B2 (fr)
BR (1)	BRPI0713058A2 (fr)
CA (1)	CA2655937A1 (fr)
IL (1)	IL196101A0 (fr)
MX (1)	MX2008016231A (fr)
NO (1)	NO20085240L (fr)
NZ (1)	NZ573843A (fr)
RU (1)	RU2434862C2 (fr)
WO (1)	WO2008001864A1 (fr)
ZA (1)	ZA200810683B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200637839A (en) *	2005-01-07	2006-11-01	Taisho Pharmaceutical Co Ltd	1-thio-d-glucitol derivatives
EP2025674A1 (fr)	2007-08-15	2009-02-18	sanofi-aventis	Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
AU2009270936B2 (en)	2008-07-15	2014-12-18	Theracos, Inc.	Deuterated benzylbenzene derivatives and methods of use
MY155418A (en) *	2008-08-28	2015-10-15	Pfizer	Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
EP2419097B1 (fr) *	2009-04-16	2013-09-25	Taisho Pharmaceutical Co., Ltd.	Composition pharmaceutique comprenant(1s)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-d-glucitol et metformin et son utilisation pour traiter le diabètes
EA021983B1 (ru)	2009-11-02	2015-10-30	Пфайзер Инк.	Производные диоксабицикло[3.2.1]октан-2,3,4-триола
WO2011107494A1 (fr)	2010-03-03	2011-09-09	Sanofi	Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
WO2011157827A1 (fr)	2010-06-18	2011-12-22	Sanofi	Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2013037390A1 (fr)	2011-09-12	2013-03-21	Sanofi	Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
EP2760862B1 (fr)	2011-09-27	2015-10-21	Sanofi	Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
PL3489226T3 (pl) *	2012-11-20	2021-08-02	Lexicon Pharmaceuticals, Inc.	Inhibitory kotransportera glukozowo-sodowego 1
EP2952206B1 (fr)	2013-02-04	2018-10-24	Taisho Pharmaceutical Co., Ltd.	Médicament à visée prophylactique ou thérapeutique pour la constipation
CN107311992B (zh) *	2013-09-09	2020-08-18	上海研健新药研发有限公司	C-芳基葡糖苷衍生物、其制备方法及其在医药上的应用
CN104693172A (zh) *	2015-02-11	2015-06-10	佛山市赛维斯医药科技有限公司	一类苯基噻吩酰胺类sglt2/sglt1双靶点抑制剂及其用途
CN106831703A (zh) *	2015-02-11	2017-06-13	佛山市赛维斯医药科技有限公司	一种腈基噻吩酰胺甲苯类双靶点抑制剂及其用途
CN104693171A (zh) *	2015-02-11	2015-06-10	佛山市赛维斯医药科技有限公司	一类含甲氧苯基噻吩酰胺类结构的双靶点抑制剂及其用途
CN106632234A (zh) *	2015-02-11	2017-05-10	佛山市赛维斯医药科技有限公司	一类烷氧噻吩酰胺类双靶点抑制剂及其用途
CN110066302B (zh)	2018-01-23	2022-12-27	广东东阳光药业有限公司	吡喃葡萄糖基衍生物及其用途
WO2019149178A1 (fr)	2018-01-31	2019-08-08	广东东阳光药业有限公司	Dérivé de glucopyranosyle et utilisation associée

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU719726B2 (en)	1996-12-26	2000-05-18	Tanabe Seiyaku Co., Ltd.	Propiophenone derivatives and process for preparing the same
PH12000002657B1 (en) *	1999-10-12	2006-02-21	Bristol Myers Squibb Co	C-aryl glucoside SGLT2 inhibitors
ES2254376T3 (es)	2000-03-17	2006-06-16	Kissei Pharmaceutical Co., Ltd.	Derivados glucopiranosiloxibencilbenceno, preparaciones medicinales que los contienen e intermediarios para la preparacion de los indicados derivados.
TWI243162B (en)	2000-11-10	2005-11-11	Taisho Pharmaceutical Co Ltd	Cyanopyrrolidine derivatives
US7217697B2 (en)	2001-05-30	2007-05-15	Kissei Pharmaceutical Co., Ltd.	Glucopyranosyloxypyrazole derivative medicinal composition containing the same medicinal use thereof and intermediate therefor
TWI254635B (en)	2002-08-05	2006-05-11	Yamanouchi Pharma Co Ltd	Azulene derivative and salt thereof
PL213095B1 (pl)	2002-08-08	2013-01-31	Kissei Pharmaceutical	Pochodna pirazolu, kompozycja farmaceutyczna, srodek do leczenia lub hamowania choroby i zastosowanie pochodnej pirazolu
RU2322449C2 (ru) *	2002-08-09	2008-04-20	Тайсо Фармасьютикал Ко., Лтд.	ПРОИЗВОДНЫЕ АРИЛ 5-ТИО-β-D-ГЛЮКОПИРАНОЗИДА И ТЕРАПЕВТИЧЕСКИЕ СРЕДСТВА ПРИ ДИАБЕТЕ, СОДЕРЖАЩИЕ ИХ
DE10239029A1 (de) *	2002-08-21	2004-03-04	Coty B.V.	Kosmetische und dermatologische Zubereitung mit Proteinen zur Hautaufhellung
JP2004137245A (ja)	2002-08-23	2004-05-13	Kissei Pharmaceut Co Ltd	ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
JP4606876B2 (ja)	2002-08-27	2011-01-05	キッセイ薬品工業株式会社	ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途
KR20050089156A (ko)	2002-12-04	2005-09-07	깃세이 야쿠힌 고교 가부시키가이샤	고혈당증에 기인하는 질환의 예방 또는 치료제
WO2004089966A1 (fr)	2003-04-01	2004-10-21	Taisho Pharmaceutical Co., Ltd.	Procede de preparation selective de 5-thio-$g(b)-d-aldohexopyranoside heteroaryle
CN1761676A (zh) *	2003-04-01	2006-04-19	大正制药株式会社	杂芳基5－硫代－β－D－吡喃葡糖苷衍生物及含有该衍生物的糖尿病治疗药
WO2004106352A1 (fr)	2003-05-29	2004-12-09	Taisho Pharmaceutical Co., Ltd.	Procede pour produire un intermediaire d'aldohexopyranose
DE102004028241B4 (de)	2004-06-11	2007-09-13	Sanofi-Aventis Deutschland Gmbh	Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
US20080090863A1 (en)	2004-09-30	2008-04-17	Taisho Pharmaceutical Co., Ltd.	Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor
WO2006051662A1 (fr)	2004-11-09	2006-05-18	Taisho Pharmaceutical Co., Ltd.	Derive de thiazole
TW200637839A (en) *	2005-01-07	2006-11-01	Taisho Pharmaceutical Co Ltd	1-thio-d-glucitol derivatives

2007
- 2007-06-28 RU RU2009102832/04A patent/RU2434862C2/ru not_active IP Right Cessation
- 2007-06-28 NZ NZ573843A patent/NZ573843A/en not_active IP Right Cessation
- 2007-06-28 JP JP2008522631A patent/JP5152519B2/ja not_active Expired - Fee Related
- 2007-06-28 MX MX2008016231A patent/MX2008016231A/es active IP Right Grant
- 2007-06-28 KR KR1020087027879A patent/KR20090023570A/ko not_active Ceased
- 2007-06-28 BR BRPI0713058-9A patent/BRPI0713058A2/pt not_active IP Right Cessation
- 2007-06-28 CA CA002655937A patent/CA2655937A1/fr not_active Abandoned
- 2007-06-28 EP EP07767824.1A patent/EP2036901B1/fr active Active
- 2007-06-28 WO PCT/JP2007/063031 patent/WO2008001864A1/fr not_active Ceased
- 2007-06-28 CN CN2007800242564A patent/CN101479254B/zh not_active Expired - Fee Related
- 2007-06-28 AU AU2007266078A patent/AU2007266078B2/en not_active Ceased
- 2007-06-28 US US12/305,157 patent/US8115017B2/en not_active Expired - Fee Related
2008
- 2008-12-15 NO NO20085240A patent/NO20085240L/no not_active Application Discontinuation
- 2008-12-18 ZA ZA2008/10683A patent/ZA200810683B/en unknown
- 2008-12-21 IL IL196101A patent/IL196101A0/en unknown

Also Published As

Publication number	Publication date
AU2007266078B2 (en)	2011-12-15
CN101479254A (zh)	2009-07-08
HK1130472A1 (en)	2009-12-31
KR20090023570A (ko)	2009-03-05
JPWO2008001864A1 (ja)	2009-11-26
EP2036901A4 (fr)	2009-11-18
NZ573843A (en)	2011-02-25
ZA200810683B (en)	2010-02-24
EP2036901A1 (fr)	2009-03-18
EP2036901B1 (fr)	2013-05-01
MX2008016231A (es)	2009-01-16
US20100004465A1 (en)	2010-01-07
BRPI0713058A2 (pt)	2012-04-10
AU2007266078A1 (en)	2008-01-03
US8115017B2 (en)	2012-02-14
IL196101A0 (en)	2009-09-01
RU2009102832A (ru)	2010-08-10
RU2434862C2 (ru)	2011-11-27
CN101479254B (zh)	2012-05-30
CA2655937A1 (fr)	2008-01-03
JP5152519B2 (ja)	2013-02-27
WO2008001864A1 (fr)	2008-01-03

Legal Events

Date	Code	Title	Description
2014-02-03	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20085240L (no)	2009-03-30	C-fenyl-1-tioglucitolforbindelse
NO20084830L (no)	2009-02-19	C-fenylglycitolforbindelse for behandling av diabetes
NO20074012L (no)	2007-10-08	1-tio-D-glucitolderivater
NO20092286L (no)	2009-08-13	Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
IL187005A0 (en)	2008-02-09	Diacylglycerol acyltransferase inhibitors
MY149622A (en)	2013-09-13	Pyrazoles as 11-beta-hsd-1
EP1400529A4 (fr)	2007-12-19	Derive de glucopyranosyloxypyrazole, composition medicinale contenant celui-ci, et utilisation medicinale et intermediaire de celui-ci
NO20074872L (no)	2007-10-30	Pyrazoler
WO2007060140A3 (fr)	2007-09-13	Inhibiteurs de diacylglycérol acyltransférase (dgat)
WO2009010416A3 (fr)	2009-03-05	Inhibiteurs de 11b-hydroxystéroïde déshydrogenase
TW200833675A (en)	2008-08-16	Nicotinamide derivatives
TW200628484A (en)	2006-08-16	1-(β-d-glycopyranosyl)-3-substituted nitrogen-containing heterocyclic compound, medicinal composition containing the same and use thereof
WO2007082808A3 (fr)	2007-09-13	Thiazoles en tant qu'inhibiteurs de 11 beta-hsd1
NO20080789L (no)	2008-02-13	1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid
NO20062583L (no)	2006-09-20	Difenylazetidinonderivater med kolesterolabsorpsjonsinhiberende aktivitet
NO20055680L (no)	2006-01-11	Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
NO20064412L (no)	2006-12-04	Kondensert heterocykelderivat, medisinsk sammensetning inneholdende det samme og medisinsk anvendelse derav
TW200800936A (en)	2008-01-01	Novel coumarin derivatives with antitumor activity
NO20076254L (no)	2008-02-27	Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander
WO2008087933A1 (fr)	2008-07-24	Nouveau dérivé d'indole ayant une activité inhibitrice sur la iκb kinase β
WO2008140099A1 (fr)	2008-11-20	Dérivés de tétrazoyl-oxime et agent de lutte contre une maladie végétale
NO20076197L (no)	2008-02-29	Nye 2-azetidinonderivater anvendbare i behandling av hyperlipidemiske tilstander
NO20062591L (no)	2006-09-20	Difenylazetidinonderivater med kolesterolabsorpsjonsinhiberende aktivitet
NO20082496L (no)	2008-07-24	Pyrazinderivater
MX2007010532A (es)	2007-10-12	Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.